nDatalyze Clinical Study Update #2 – June 11, 2024

NEWS RELEASE

 

nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) Clinical Study Update #2.

 

Calgary, Alberta – June 11, 2024

For Immediate Release – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) ) The Corporation has been advised of further preliminary results of the York University clinical study related to the Corporation’s YMI mental condition assessment program. The model has been further refined to target overdiagnosis and is currently generating 93% precision (or “positive predictive value”) when using psychiatrist/psychologist diagnoses as the “ground truth”.

Jim Durward, CEO/CTO states: “Mental condition diagnoses are generated by three disciplines: Psychiatrists (medical doctors who are also highly-trained in “matters of the mind” and who can prescribe psychotropic drugs), Psychologists (persons who are not a medical doctors but are highly-trained in matters of the mind, but who cannot prescribe drugs), or Primary Physicians (family doctors – medical doctors with little mental condition training but who can prescribe psychotropic drugs). Our model uses only Psychiatrist/Psychologist diagnoses as the “ground truth” as these are the disciplines with high degrees of mental condition training.”

According to Johns Hopkins Bloomberg School of Public Health, Americans are over-diagnosed and over-treated for depression. One of their studies examined adults with clinician-identified depression and individuals who experienced major depressive episodes within a 12-month period. It found that when assessed for major depressive episodes using a structured interview, only 38.4 percent of adults with clinician-identified depression met the 12-month criteria for depression, despite the majority of participants being prescribed and using psychiatric medications (Source: https://publichealth.jhu.edu/2013/mojtabai-depression-over-diagnosis-and-over-treatment)

Once complete, the York study is expected to demonstrate the benefit of combining DNA data with environmental biometric data when predicting depression susceptibilities.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

James Durward, CEO&CTO

Email: [email protected]

nDatalyze Website: www.ndatalyze.com

YMI Website: ymihealth.ca

 

ABOUT MINDBALANCED INC.:

Mindbalanced’s vision is to redefine mental healthcare through an integrative, personalized approach leveraging cutting edge technology and non-invasive treatment protocols. By harnessing evidence-based data we aim to predict and enhance mental wellbeing, taking into account individual predispositions and environmental factors thereby fostering healthier and more fulfilling lives for all.

 

ABOUT YMI:

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops, and how to improve mental wellbeing. YMI combines supervised machine-learning with a proprietary Reference Database to predict an individual’s predisposition toward a variety of common mental conditions, both current and forward in time. YMI is poised to revolutionize mental health diagnoses while ensuring a sustainable revenue stream. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies, and targeting key markets, YMI aligns both societal impact and financial success.

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.